Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin ; volume:05 ; number:02 ; year:2016 ; pages:063-066
South Asian journal of cancer ; 05, Heft 02 (2016), 063-066
- Contributor
-
Dessai, S. B.
Chakraborty, S.
Babu, T. V.S.
Nayanar, S.
Bhattacharjee, A.
Jones, J.
Balasubramanian, S.
Patil, Vijay M.
- DOI
-
10.4103/2278-330X.181629
- URN
-
urn:nbn:de:101:1-2021022618505494746800
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dessai, S. B.
- Chakraborty, S.
- Babu, T. V.S.
- Nayanar, S.
- Bhattacharjee, A.
- Jones, J.
- Balasubramanian, S.
- Patil, Vijay M.
Other Objects (12)
Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study
A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma
Paclitaxel und Paclitaxel-Carboplatin beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom : Auswertung klinischer Phase-II-Studien
Weekly versus biweekly high-dose rate brachytherapy schedules in carcinoma cervix following concomitant chemoradiation with paclitaxel and carboplatin
Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience
Nab-Paclitaxel + Carboplatin bei fortgeschrittenem NSCLC : Fallsamlung von 7 Kasuistiken
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer
Die Behandlung des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms mit Paclitaxel und Carboplatin
Einfluss von Paclitaxel und Carboplatin auf das Hitzeschockprotein 27 in Ovarialkarzinomzellen
Validity of Weekly Administration of Carboplatin after Carboplatin-Induced SIADH: Two Case Reports and Literature Review
Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study
A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma
Paclitaxel und Paclitaxel-Carboplatin beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom : Auswertung klinischer Phase-II-Studien
Weekly versus biweekly high-dose rate brachytherapy schedules in carcinoma cervix following concomitant chemoradiation with paclitaxel and carboplatin
Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience
Nab-Paclitaxel + Carboplatin bei fortgeschrittenem NSCLC : Fallsamlung von 7 Kasuistiken
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer
Die Behandlung des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms mit Paclitaxel und Carboplatin
Einfluss von Paclitaxel und Carboplatin auf das Hitzeschockprotein 27 in Ovarialkarzinomzellen
Validity of Weekly Administration of Carboplatin after Carboplatin-Induced SIADH: Two Case Reports and Literature Review
Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study
A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma
Paclitaxel und Paclitaxel-Carboplatin beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom : Auswertung klinischer Phase-II-Studien
Weekly versus biweekly high-dose rate brachytherapy schedules in carcinoma cervix following concomitant chemoradiation with paclitaxel and carboplatin
Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience
Nab-Paclitaxel + Carboplatin bei fortgeschrittenem NSCLC : Fallsamlung von 7 Kasuistiken
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer
Die Behandlung des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms mit Paclitaxel und Carboplatin
Einfluss von Paclitaxel und Carboplatin auf das Hitzeschockprotein 27 in Ovarialkarzinomzellen
Validity of Weekly Administration of Carboplatin after Carboplatin-Induced SIADH: Two Case Reports and Literature Review